IndexIQ Advisors’s Collegium Pharmaceutical COLL Stock Holding History

IndexIQ Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$416K	Buy	20,416 +2,597	+15%	+$49.1K	0.01%	478
2021 Q4	$333K	Sell	17,819 -1,151	-6%	-$22.4K	0.01%	899
2021 Q3	$374K	Buy	18,970 +1,900	+11%	+$41.1K	0.01%	875
2021 Q2	$404K	Buy	17,070 +235	+1%	+$5.43K	0.01%	698
2021 Q1	$399K	Buy	16,835 +4,009	+31%	+$95.2K	0.01%	726
2020 Q4	$257K	Buy	12,826 +1,324	+12%	+$25.9K	0.01%	779
2020 Q3	$239K	Buy	11,502 +624	+6%	+$11.3K	0.01%	514
2020 Q2	$190K	Sell	10,878 -179	-2%	-$3.5K	0.01%	637
2020 Q1	$181K	Buy	+11,057	New	+$228K	0.01%	644

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

IndexIQ Advisors's COLL Position: Q1 2022 in Review

IndexIQ Advisors increased its Collegium Pharmaceutical (COLL) stake by 15% in Q1 2022, buying an estimated $49.1K and bringing the position to 20,416 shares worth $416K. The position accounts for 0.01% of the portfolio, ranked #478.

IndexIQ Advisors first reported a position in COLL in Q1 2020 and has held it in 9 quarters since. 172 funds tracked by Wall St. Rank hold COLL as of Q1 2022.

IndexIQ Advisors held 20,416 shares of Collegium Pharmaceutical worth $416K as of Q1 2022.
IndexIQ Advisors bought 2,597 Collegium Pharmaceutical shares in Q1 2022, an estimated $49.1K.
Collegium Pharmaceutical made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #478 holding.
IndexIQ Advisors first reported a position in Collegium Pharmaceutical in Q1 2020 and has held it in 9 quarters since.
172 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.